Home » Piramal Buys Drug Rights From Cipla for $21 Million
Piramal Buys Drug Rights From Cipla for $21 Million
Piramal Healthcare has bought the rights for Cipla’s emergency contraceptive drug brand, i-pill, for 950 million rupees ($21 million), a senior official
said.
The Economic Times
The Economic Times
Upcoming Events
-
07May
-
14May
-
30May